One of the most agonizing experiences a cancer patient suffers is waiting without knowing: waiting for a diagnosis, waiting ...

This research team evaluated the effectiveness of switching patients to faricimab treatment by assessing their outcomes after ...

Interior Design Show returned in late January to the 180,000-square-foot North Building of the Metro Toronto Convention ...

Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ:EYPT) fell 21% today, diverging from the company's recent ...

WATERTOWN, Mass. - EyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ:EYPT), currently valued at $535 million, announced positive results from the Phase 2 VERONA clinical trial of DURAVYU™, its ...

Despite these positive outcomes, EyePoint's stock experienced a sharp decline. Cantor Fitzgerald analyst Jennifer Kim commented on the market reaction, stating, "There's nothing here that makes us ...

The ranibizumab injection could be administered in a convenient schedule twice per year for the treatment of diabetic macular ...

An MTF2-containing subcomplex of Polycomb Repressive Complex 2 promotes cell cycle progression through repression of D-type cyclin expression in certain cellular contexts.

Hypothetical devices that can quickly and accurately answer questions have become a powerful tool in computational complexity theory.

If Florida Republicans are looking for a smooth transition from DeSantis to whoever comes next, they've likely misjudged the turf - .

The mobile application industry has now started growing at an exponential level. Mobile apps’ revenue for the global market is estimated to reach $935 billion in the future, based on Statista.

The GaGe RazorMax Express CompuScope digitizer streamlines particle counting, combining multichannel analysis with ...